Laboratorios Farma | ROVI - Selling And Administration Expenses


Laboratorios Farma reported EUR35.32M in Selling and Administration Expenses for its fiscal semester ending in June of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 424K 23K Jun/2026
Almirall -29.5M 4.72M Jun/2026
Avita Medical AUD 19.54M 516K Jun/2026
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Ionis Pharmaceuticals USD 154M 23.92M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Moderna USD 282M 66M Sep/2026
Organon & Co USD 407M 27M Sep/2026
Pharma Mar EUR 15.53M 1.59M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Tectonic Therapeutic USD 6.17M 260K Jun/2026
Viatris USD 950.8M 183.7M Sep/2026
Xeris Pharmaceuticals USD 61.04M 7.89M Jun/2026